AF single shot ablations and DCCV
Reconstitution
Byfavo 20 mg - reconstitute with 8.2 mL NaCl 0.9% to give a final concentration of 2.5 mg/mL.
Appropriate patient selection: BMI <35 and no severe sleep apnoea
Airway assessed
Baseline BP / ECG / SpO2 / respiratory rate
Oxygen and suction available
Bag-mask and airway adjuncts available
Defibrillator / ALS equipment available
Flumazenil available
Naloxone available if fentanyl used
Warning
Use capnography if verbal contact is lost.
Patient criteria: <65 years, ASA I-II and ≥50 kg.
This pathway applies if any of the following are present: ≥65 years, ASA III-IV, <50 kg, or frailty.
Use the lower end of the dose range when several risk factors coexist.
Give remimazolam 2.5 mg IV over approximately 15 seconds.
Wait before repeating
Wait at least 2 minutes before repeating. Do not give repeated rapid boluses.
If 5 doses within 15 minutes fail, stop and reassess the sedation strategy.
Remimazolam is not analgesia
If pain or distress persists, give fentanyl 25 micrograms IV, then reassess.
Aim for approximately 5 minutes or more between supplemental fentanyl doses.
Increasing opioid requirement should prompt reassessment rather than repeated escalation of fentanyl and remimazolam.
Patient criteria: <65 years, ASA I-II and ≥50 kg.
For patients who are ≥65 years, ASA III-IV, or <50 kg:
Stop drugs
Ventilation takes priority over reversal medication.
For clinically significant benzodiazepine sedation:
Warning
Flumazenil does not reverse fentanyl. Continue monitoring after reversal.
Stop and reassess if: